162 related articles for article (PubMed ID: 16219326)
1. N-terminally truncated variant of the mouse GAIP/RGS19 lacks selectivity of full-length GAIP/RGS19 protein in regulating ORL1 receptor signaling.
Xie GX; Yanagisawa Y; Ito E; Maruyama K; Han X; Kim KJ; Han KR; Moriyama K; Palmer PP
J Mol Biol; 2005 Nov; 353(5):1081-92. PubMed ID: 16219326
[TBL] [Abstract][Full Text] [Related]
2. Gene structure, dual-promoters and mRNA alternative splicing of the human and mouse regulator of G protein signaling GAIP/RGS19.
Xie GX; Han X; Ito E; Yanagisawa Y; Maruyama K; Sugano S; Suzuki Y; Wang Y; Gabriel A; Stevens SK; Mitchell J; Sharma M; Palmer PP
J Mol Biol; 2003 Jan; 325(4):721-32. PubMed ID: 12507475
[TBL] [Abstract][Full Text] [Related]
3. A core-promoter region functions bi-directionally for human opioid-receptor-like gene ORL1 and its 5'-adjacent gene GAIP.
Ito E; Xie G; Maruyama K; Palmer PP
J Mol Biol; 2000 Dec; 304(3):259-70. PubMed ID: 11090272
[TBL] [Abstract][Full Text] [Related]
4. Modulation of μ-opioid receptor signaling by RGS19 in SH-SY5Y cells.
Wang Q; Traynor JR
Mol Pharmacol; 2013 Feb; 83(2):512-20. PubMed ID: 23197645
[TBL] [Abstract][Full Text] [Related]
5. An alternatively spliced transcript of the rat nociceptin receptor ORL1 gene encodes a truncated receptor.
Xie G; Ito E; Maruyama K; Pietruck C; Sharma M; Yu L; Pierce Palmer P
Brain Res Mol Brain Res; 2000 Apr; 77(1):1-9. PubMed ID: 10814826
[TBL] [Abstract][Full Text] [Related]
6. RGSZ1 and GAIP regulate mu- but not delta-opioid receptors in mouse CNS: role in tachyphylaxis and acute tolerance.
Garzón J; Rodríguez-Muñoz M; López-Fando A; García-España A; Sánchez-Blázquez P
Neuropsychopharmacology; 2004 Jun; 29(6):1091-104. PubMed ID: 14997173
[TBL] [Abstract][Full Text] [Related]
7. Regulator of G-protein signalling expression and function in ovarian cancer cell lines.
Hurst JH; Mendpara N; Hooks SB
Cell Mol Biol Lett; 2009; 14(1):153-74. PubMed ID: 18979070
[TBL] [Abstract][Full Text] [Related]
8. Regulator of G protein signaling proteins differentially modulate signaling of mu and delta opioid receptors.
Xie Z; Li Z; Guo L; Ye C; Li J; Yu X; Yang H; Wang Y; Chen C; Zhang D; Liu-Chen LY
Eur J Pharmacol; 2007 Jun; 565(1-3):45-53. PubMed ID: 17433292
[TBL] [Abstract][Full Text] [Related]
9. Histamine H(4) receptor-RGS fusion proteins expressed in Sf9 insect cells: a sensitive and reliable approach for the functional characterization of histamine H(4) receptor ligands.
Schneider EH; Seifert R
Biochem Pharmacol; 2009 Sep; 78(6):607-16. PubMed ID: 19464266
[TBL] [Abstract][Full Text] [Related]
10. Cloning, pharmacological characterization and tissue distribution of an ORL1 opioid receptor from an amphibian, the rough-skinned newt Taricha granulosa.
Walthers EA; Bradford CS; Moore FL
J Mol Endocrinol; 2005 Feb; 34(1):247-56. PubMed ID: 15691892
[TBL] [Abstract][Full Text] [Related]
11. GIPC recruits GAIP (RGS19) to attenuate dopamine D2 receptor signaling.
Jeanneteau F; Guillin O; Diaz J; Griffon N; Sokoloff P
Mol Biol Cell; 2004 Nov; 15(11):4926-37. PubMed ID: 15356268
[TBL] [Abstract][Full Text] [Related]
12. Heterodimerization of opioid receptor-like 1 and mu-opioid receptors impairs the potency of micro receptor agonist.
Wang HL; Hsu CY; Huang PC; Kuo YL; Li AH; Yeh TH; Tso AS; Chen YL
J Neurochem; 2005 Mar; 92(6):1285-94. PubMed ID: 15748148
[TBL] [Abstract][Full Text] [Related]
13. Differential modulation of mu- and delta-opioid receptor agonists by endogenous RGS4 protein in SH-SY5Y cells.
Wang Q; Liu-Chen LY; Traynor JR
J Biol Chem; 2009 Jul; 284(27):18357-67. PubMed ID: 19416973
[TBL] [Abstract][Full Text] [Related]
14. Ligands for kappa-opioid and ORL1 receptors identified from a conformationally constrained peptide combinatorial library.
Becker JA; Wallace A; Garzon A; Ingallinella P; Bianchi E; Cortese R; Simonin F; Kieffer BL; Pessi A
J Biol Chem; 1999 Sep; 274(39):27513-22. PubMed ID: 10488086
[TBL] [Abstract][Full Text] [Related]
15. Nociceptin activation of the human ORL1 receptor expressed in Chinese hamster ovary cells: functional homology with opioid receptors.
Fawzi AB; Zhang H; Weig B; Hawes B; Graziano MP
Eur J Pharmacol; 1997 Oct; 336(2-3):233-42. PubMed ID: 9384238
[TBL] [Abstract][Full Text] [Related]
16. Quantitative autoradiographic mapping of the ORL1, mu-, delta- and kappa-receptors in the brains of knockout mice lacking the ORL1 receptor gene.
Clarke S; Chen Z; Hsu MS; Pintar J; Hill R; Kitchen I
Brain Res; 2001 Jul; 906(1-2):13-24. PubMed ID: 11430857
[TBL] [Abstract][Full Text] [Related]
17. Mu-opioid-induced desensitization of opioid receptor-like 1 and mu-opioid receptors: differential intracellular signaling determines receptor sensitivity.
Mandyam CD; Thakker DR; Standifer KM
J Pharmacol Exp Ther; 2003 Sep; 306(3):965-72. PubMed ID: 12750434
[TBL] [Abstract][Full Text] [Related]
18. Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and mu opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk.
Mandyam CD; Thakker DR; Christensen JL; Standifer KM
J Pharmacol Exp Ther; 2002 Aug; 302(2):502-9. PubMed ID: 12130708
[TBL] [Abstract][Full Text] [Related]
19. Different domains of the ORL1 and kappa-opioid receptors are involved in recognition of nociceptin and dynorphin A.
Lapalu S; Moisand C; Butour JL; Mollereau C; Meunier JC
FEBS Lett; 1998 May; 427(2):296-300. PubMed ID: 9607332
[TBL] [Abstract][Full Text] [Related]
20. Autoradiographic mapping of the opioid receptor-like 1 (ORL1) receptor in the brains of mu-, delta- or kappa-opioid receptor knockout mice.
Slowe SJ; Clarke S; Lena I; Goody RJ; Lattanzi R; Negri L; Simonin F; Matthes HW; Filliol D; Kieffer BL; Kitchen I
Neuroscience; 2001; 106(3):469-80. PubMed ID: 11591451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
